Tenax Therapeutics

About:

Tenax Therapeutics focuses on identifying and developing treatments that address cardiovascular and pulmonary diseases.

Website: http://www.tenaxthera.com

Twitter/X: TenaxThera

Top Investors: Venrock Healthcare Capital Partners, Vivo Capital, Stonepine Capital Management, Vestal Point Capital, ADAR1 Capital Management

Description:

Tenax Therapeutics is a pharmaceutical company that focuses on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. Tenax Therapeutics develops novel dosing and formulations of imatinib mesylate, a kinase inhibitor for the treatment of pulmonary arterial hypertension. Imatinib, which acts on underlying cellular proliferative pathways linked to PAH, has the potential to be the first disease-modifying therapy for the disease.